Document is current
Any future updates will be listed below
-
Authors
Francis, Catherine M. https://orcid.org/0000-0002-4370-9461
Futschik, Matthias E.
Huang, Jian
Bai, Wenjia https://orcid.org/0000-0003-2943-7698
Sargurupremraj, Muralidharan
Teumer, Alexander https://orcid.org/0000-0002-8309-094X
Breteler, Monique M. B. https://orcid.org/0000-0002-0626-9305
Petretto, Enrico https://orcid.org/0000-0003-2163-5921
Ho, Amanda S. R. https://orcid.org/0000-0003-2166-4503
Amouyel, Philippe https://orcid.org/0000-0001-9088-234X
Engelter, Stefan T.
Bülow, Robin
Völker, Uwe https://orcid.org/0000-0002-5689-3448
Völzke, Henry
Dörr, Marcus https://orcid.org/0000-0001-7471-475X
Imtiaz, Mohammed-Aslam
Aziz, N. Ahmad https://orcid.org/0000-0001-6184-458X
Lohner, Valerie https://orcid.org/0000-0001-5589-9701
Ware, James S. https://orcid.org/0000-0002-6110-5880
Debette, Stephanie https://orcid.org/0000-0001-8675-7968
Elliott, Paul https://orcid.org/0000-0002-7511-5684
Dehghan, Abbas https://orcid.org/0000-0001-6403-016X
Matthews, Paul M. https://orcid.org/0000-0002-1619-8328
- License Information
-
More Information
Article History
Received: 19 August 2021
Accepted: 20 July 2022
First Online: 3 August 2022
Competing interests
: P.M.M. acknowledges consultancy fees from Novartis, Bristol–Myers Squibb, Celgene and Biogen. He has received honoraria or speakers’ honoraria from Novartis, Biogen and Roche and has received research or educational funds from Biogen, Novartis, GlaxoSmithKline and Nodthera. J.S.W. has acted as a consultant for MyoKardia and Foresite Labs, and received research support from MyoKardia & Bristol–Myers Squibb. The remaining authors declare no competing interests.
